Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Operating Income (2016 - 2025)

Historic Operating Income for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $82.5 million.

  • Prestige Consumer Healthcare's Operating Income fell 1029.88% to $82.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $322.3 million, marking a year-over-year decrease of 246.75%. This contributed to the annual value of $336.8 million for FY2025, which is 165.11% down from last year.
  • As of Q4 2025, Prestige Consumer Healthcare's Operating Income stood at $82.5 million, which was down 1029.88% from $79.7 million recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Operating Income ranged from a high of $92.0 million in Q4 2024 and a low of -$281.0 million during Q1 2023
  • Moreover, its 5-year median value for Operating Income was $83.5 million (2021), whereas its average is $64.6 million.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Operating Income plummeted by 46292.8% in 2023 and then surged by 12923.63% in 2024.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Operating Income stood at $82.6 million in 2021, then grew by 5.56% to $87.2 million in 2022, then decreased by 0.4% to $86.8 million in 2023, then rose by 5.91% to $92.0 million in 2024, then decreased by 10.3% to $82.5 million in 2025.
  • Its Operating Income stands at $82.5 million for Q4 2025, versus $79.7 million for Q3 2025 and $71.8 million for Q2 2025.